★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

News/Compliance & Enforcement/2023 False Claims Act Enforcement in Health Care and Life Sciences, Part II
Expert Opinion·Compliance & Enforcement Brief

2023 False Claims Act Enforcement in Health Care and Life Sciences, Part II

Jones Day – In the second part of their series on FCA enforcement in the Life Sciences sector, Jones Day discusses 2023 FCA matters involving the Anti-Kickback Statute and Stark Law, Medicare Advantage (Part C), cybersecurity, pandemic fraud, as well as the crescendo of public statements from federal regulators about private equity and corporate ownership in the health care and life sciences space.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.